PubMed Health⌕ Search

Biomedical subjects

M E Gluck

Publications and source records attributed to M E Gluck.

4 recordsLinked to original sources
PubMed2001

Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients.

OBJECTIVE: The objective of this study was to assess the relationship between the night eating syndrome (NES), measures of depression and self-esteem, test meal intake, and weight loss in obese participants. RESEARCH METHODS AND PROCEDURES: The study included 76 overweight (body mass index = 36.7 +/- 6.5 SD) outpatients (53 women and 23 men; aged 43.5 +/- 9.5 years) entering a weight loss program. They completed a Night Eating Questionnaire, the Zung Depression Inventory, and the Rosenberg Self-Esteem SCALE: Based on criteria by Stunkard et al. (Stunkard A, Berkowitz R, Wadden T, Tanrikut C, Reiss E, Young L. Binge eating disorder and the night eating syndrome. Int J Obes Relat Metab DISORD: 1996;20:1-6), participants had NES if they reported: (1) skipping breakfast > or =4 d/wk, interpreted as morning anorexia; (2) consuming more than 50% of total daily calories after 7 PM; and (3) difficulty falling asleep or staying asleep > or =4 d/wk. Eleven (14%) participants met the criteria for NES. After an 8-hour fast, all participants ingested a nutritionally complete liquid meal through a straw from a large opaque cooler until extremely full. They also completed ratings of hunger and fullness before and after this meal. RESULTS: Night eaters had higher depression (p = 0.04), lower self-esteem (p = 0.003), and less hunger (p = 0.005), and a trend for more fullness (p = 0.06) before the daytime test meal than the others. However, there were no significant differences in test-meal intake between groups. Nevertheless, test-meal intake was greater later in the day only for the night eaters (p = 0.01). Over a 1-month period, the night eaters lost less weight (4.4 +/- 3.2 kg) than the others (7.3 +/- 3.2 kg; p = 0.04), after controlling for body mass index. DISCUSSION: NES is a syndrome with distinct psychopathology and increased food intake later in the day, both of which may contribute to poorer weight loss outcome. NES criteria need to be better quantified and NES deserves consideration as a diagnostic eating disorder.

Adult↗
PubMed2000

Work-shift period and weight change.

The present study was done to determine whether weight gain was more prevalent in workers on late shifts than in those on day shifts. A questionnaire about changes in weight, food intake, exercise, and sleep since starting the job on the current shift was given to day-shift and late-shift (evening and night) hospital workers. Data were analyzed for 85 subjects, 36 of whom worked during the day shift and 49 the late shift. The late-shift group reported a mean weight gain of 4.3 kg, which was greater than the mean weight gain of 0.9 kg for the day-shift group (P = 0.02). There were, however, no significant differences in current body mass index (26.7 +/- 5.4 SD) between groups. There was a trend for late-shift workers to report eating more since beginning the later shift (P = 0.06). When combined with those reporting exercising less (P = NS), this trend became significant (P = 0.04). Late-shift workers reported eating fewer meals (1.9 +/- 0.9 SD) than the day-shift workers (2.5 +/- 0.9; P = 0.002). In addition, late-shift workers reported eating the last daily meal later (mean = 22:27, or 10:27 PM) than day-shift workers (17:52 or 5:52 PM; P < 0.00005). Late-shift workers also reported more naps (P = 0.01) and longer naps (P = 0.05) during the work week than did day-shift workers. The reported changes in eating, exercise, and sleep may contribute to the increased weight gain of late-shift workers.

Adult↗
PubMed1999

A Medicare prescription drug benefit.

Even though almost two-thirds of Medicare beneficiaries have some coverage for outpatient prescription drugs, pharmaceuticals are a major part of their out-of-pocket expenses and threaten the financial security of growing numbers of beneficiaries. Because pharmaceuticals are an integral part of modern health care, some have proposed adding a drug benefit to Medicare. Such proposals pose difficult questions of design, cost, and administration. A drug benefit could add between 7 and 13 percent per year to Medicare costs over the next decade. If such a benefit were added to Medicare, policymakers would have to decide who should bear these costs and whether subsidies should be provided to help lower income beneficiaries pay the portion of the costs borne by participants.

Financing, Personal↗